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ABSTRACT The effect of the covalent attachment of a myristoyl moiety to the N-terminal glycine residue in proteins,
N-myristoylation, on lipid-protein interactions was investigated in a model system using magnetic resonance spectroscopic
methods. Two peptides with sequences conserved among known N-myristoylated proteins were chosen for this study. Using
two-dimensional nuclear magnetic resonance techniques, it was shown that N-myristoylation results in an aggregation of both
peptides in solution, although they lack well defined folded conformations in solution either when chemically N-myristoylated
or when nonacylated. The interaction of the acylated peptides with lipid bilayers was investigated using spin label electron spin
resonance and 2H NMR techniques. The results show that when bound to membranes, the covalently linked myristoyl chain
of one of the peptides is directly inserted into or anchored to the lipid bilayer. The binding of the other peptide with membranes
is effected by interactions between amino acid residues and the phospholipid headgroups. In this case, the covalently linked
myristoyl moiety is most likely not in direct contact with the acyl chains of the host lipid bilayer. Rather, the N-myristoyl chains
stabilize the peptide aggregate by forming a hydrophobic core. Measurements of peptide binding to membranes showed that
N-myristoylation affects both the lipid:peptide stoichiometry at saturation and the equilibrium binding constant, in a manner that
is consistent with the structural information obtained by magnetic resonance methods.
INTRODUCTION
A novel type of protein modification discovered in recent
years, N-myristoylation, involves the covalent attachment of
myristic acid to N-terminal amino groups of glycine residues
in soluble proteins (Schultz et al., 1988; Towler et al., 1988;
Schmidt, 1989; Gordon et al., 1991). N-myristoylated pro-
teins exist in a wide variety of organisms including viruses,
fungi, yeast, angiosperms, sea urchin, vertebrates, and mam-
mals. Many eukaryotic and viral proteins related to regula-
tion of cell growth and/or signal transduction, e.g., enzymes,
a-subunits of G-proteins, immunoglobulins, and growth fac-
tors are N-myristoylated. N-myristoylation is catalyzed by
N-myristoyl transferase (Towler et al., 1987). Interestingly,
not all proteins with an N-terminal glycine are myristoylated
in vivo (Buss et al., 1987), although synthetic peptides of
their N-terminal regions can be myristoylated in vitro
(Towler et al., 1988).
An examination of the primary sequences of
N-myristoylated proteins reveals a consensus sequence for
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the N-terminal region of the proteins (Schultz et al., 1988).
An N-terminal glycine is an absolute requirement for N-
myristoylation. The second and fifth positions may be oc-
cupied by most amino acids except proline and those with
bulky side chains. No specific amino acid requirement was
found for the third and fourth positions. A majority of
N-myristoylated proteins contain serine as the fifth residue,
whereas threonine is the next most highly conserved residue
at the fifth position (Gordon et al., 1991). Although it is
generally assumed that N-myristoylation helps to anchor a
protein to the membrane, clear biochemical evidence for this
assumption has not been forthcoming.
One way to study the structural, functional, and mecha-
nistic consequences of N-myristoylation is to study its effect
on a well characterized system. In this paper, the solution
conformations and interactions with lipid bilayers of two
peptides, whose sequences correspond to the sequence simi-
larity features mentioned above, in both acylated and deac-
ylated forms are examined. One of the peptides has the pri-
mary sequence Gly-Gly-Asp-Ala-Ser-Gly-Glu (SerPep).
This peptide was chosen because it contains the obligatory
glycine residue at the N-terminal, a serine at the fifth position
(hence, the abbreviation SerPep) and a non-bulky residue,
glycine, at the second position. This sequence resembles
closely the N-terminal region in proteins such as the
a-subunit of the heterotrimeric G-protein transducin (Tanaba
et al., 1985), the polypeptide VP4 from polio virus (Hughes
et al., 1986), p6Osrc (Pellman et al., 1985). The other peptide
has a primary sequence Gly-Arg-Gly-Asp-Thr-Pro (ThrPep).
This peptide was chosen for two reasons. First, this peptide
contains the obligatory glycine residue at the N-terminal, and
the second most abundant residue, threonine, at the fifth
position (hence, the abbreviation ThrPep). Second, it
corresponds closely to the N-terminal region of proteins
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such as the Moloney murine leukemia virus pl5gag protein
(van Beveren et al., 1981) and the polyprotein PrO5gag, which
contain an N-terminal glycine and a threonine at position 5
(Schultz et al., 1988).
MATERIALS AND METHODS
Materials
DMPC was purchased from Avanti Chemical Company (Alabaster, AL).
The peptide SerPep was purchased from Calbiochem Corporation (La Jolla,
CA), and the peptide ThrPep was from Bachem Feinchemikalien AG
(Bubendorf, Switzerland). 1-Hydroxybenzotriazole and 1-ethyl-3-(3-di-
methylaminopropyl) carbodiimide, 16-SASL, and perdeuterated myristic
acid were purchased from Sigma Chemical Co. (St. Louis, MO). The phos-
pholipid spin label, 16-PCSL, was synthesized as described before
(Sankaram and Thompson, 1990a).
N-acylation of the peptides
Both of the peptides were better than 98.8% pure as determined by the
supplier using high pressure liquid chromatography (HPLC) and were used
without further purification. The N-myristoylated derivatives of SerPep and
ThrPep were synthesized by a covalent linkage of myristic acid to the
N-terminal amino group of the glycine residue. To do so, first the free
carboxyl groups of the peptide were methyl-esterified. N-myristoylation
was then carried out using standard carbodiimide/1-hydroxybenzotriazole-
mediated coupling reaction between the fatty acid and the protected peptide
(Konig and Geiger, 1970), followed by base hydrolysis to deprotect the
peptides. The peptides were purified by HPLC on a Vydac C18 reverse-
phase column employing an acetonitrile-water or methanol-water (each with
0.1% trifluoroacetic acid) linear gradient elution mode with a flow rate of
2 ml/min and detection at 230 nm. The deuterated peptides, Myr-d27-
SerPep and Myr-d27-ThrPep, and the spin-labeled peptides, 16-SteSL-
SerPep and 16-SteSl-ThePep, were synthesized and purified by the meth-
ods described above using perdeuterated myristic acid or the spin-labeled
fatty acid 16-SASL. After purification by HPLC, the peptides were
lyophilized and stored at -70°C.
The acylated peptides were characterized by two-dimensional
(2D) proton NMR (see below), the results of which are summarized
in Table 1. Because the method used to synthesize the spin-labeled
and deuterated acylated peptides was the same as that for unlabeled
acylated peptides, the isotopically labeled acylated peptides most
likely have the same structure.
Lipid-peptide binding studies
Large unilamellar vesicles (LUVs) of 1 gm diameter from DMPC were
formed in a Tris buffer (10 mM Tris, pH 7.4) at a lipid concentration of
13 mM using standard methods (Hope et al., 1985). A 1-ml solution in
Tris buffer of peptide, in the concentration range 0.1 and 4 mM as re-
quired, was added to LUVs. The mixture was incubated at 40°C for 24 h.
The peptide-bound LUVs were repeatedly freeze-thawed to form multi-
lamellar vesicles (MLVs). After several freeze-thaw cycles, the MLVs
were separated into a pellet and a supernatant fraction using bench-top
centrifugation. The pellets and supernatants were assayed for lipid and
TABLE 1 1H chemical shifts of the amino acid and fatty acid residues in SerPep, ThrPep, MyrSerPep, and MyrThrPep
Amino acid! Chemical shifts (ppm)
Peptide fatty acid residue NH aH ,BH Side-chain protons/fatty acid protons'
SerPep Gly 1 - 3.92
SerPep Gly 2 8.38 3.96 -
SerPep Asp 3 8.44 4.75 2.83, 2.72 -
SerPep Ala 4 8.76 4.27 1.18 -
SerPep Ser 5 8.21 4.61 3.81, 3.79 -
SerPep Gly 6 8.33 3.93
SerPep Glu 7 8.60 4.71 2.10, 1.99 -yCH2 2.52
MyrSerPep CH3 14 - - - 0.89
MyrSerPep (CH2)10 4-13 - - - 1.23
MyrSerPep CH2 3 - - - 1.62
MyrSerPep CH2 2 - - - 2.28
MyrSerPep Gly 1 8.45 3.99 -
MyrSerPep Gly 2 8.42 3.98 -
MyrSerPep Asp 3 8.46 4.75 2.83, 2.72 -
MyrSerPep Ala 4 8.76 4.27 1.18 -
MyrSerPep Ser 5 8.20 4.62 3.81, 3.79 -
MyrSerPep Gly 6 8.33 3.93 -
MyrSerPep Glu 7 8.59 4.70 2.10, 1.99 yCH2 2.52
ThrPep Gly 1 - 3.93 -
ThrPep Arg 2 8.29 4.37 1.89, 1.78 yCH2 1.70; 8CH2 3.32; NH 7.17, 6.61
ThrPep Gly 3 8.38 3.92 -
ThrPep Asp 4 8.43 4.78 2.84, 2.75
ThrPep Thr 5 8.29 4.32 4.22 -yCH3 1.23
ThrPep Pro 6 - 4.42 2.28, 2.01 yCH2 2.03; &CH2 3.68, 3.63
MyrThrPep CH3 14 - - - 0.90
MyrThrPep (CH2)10 4-13 - - - 1.23
MyrThrPep CH2 3 - - - 1.63
MyrThrPep CH2 2 - - - 2.31
MyrThrPep Gly 1 8.44 3.95 -
MyrThrPep Arg 2 8.31 3.37 1.89, 1.78 yCH2 1.79; 8CH2 3.32; NH 7.17, 6.61
MyrThrPep Gly 3 8.41 3.93 -
MyrThrPep Asp 4 8.43 4.78 2.84, 2.75
MyrThrPep Thr 5 8.31 4.31 4.22 yCH3 1.23
MyrThrPep Pro 6 - 4.42 2.28, 2.01 yCH2 2.03; SCH2 3.68, 3.63
'The myristic acid moiety is numbered from 1-14 starting at the carbonyl group covalently linked to the N-terminal glycine.
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peptide content using standard procedures (Eibl and Lands, 1969; Lowry
et al., 1951). No lipid was found in the supematant fractions. The lipid:
peptide ratios throughout the manuscript are bound lipid:peptide mole
ratios, unless otherwise indicated.
ESR spectroscopy
ESR spectra were recorded on a Varian E-Line 9 GHz spectrometer
equipped with a temperature controller, employing the sample prepa-
ration procedures described before (Sankaram and Thompson, 1990a).
A modulation amplitude of 1 G and spectral width of 100 G were
used.
2D NMR spectroscopy
NMR samples were prepared at a concentration of about 10 mM in 90%
H20/10% D20 at pH 7.4. The pH meter reading was used without any
correction for the deuterium isotope effect. NMR experiments were per-
formed at 25°C on a GN-Omega spectrometer operating at 500 MHz for
protons. The 2D experiments, double-quantum-filtered correlation spec-
troscopy (DQF-COSY), and phase-sensitive nuclear Overhauser spectros-
copy (NOESY), were performed according to standard procedures
(Wuthrich, 1986) using quadrature detection in both dimensions. The car-
rier frequency was centered on the water signal with sweep widths of
4,000 Hz in both dimensions. The solvent signal was suppressed by a sol-
vent suppression sequence (Bax, 1985). The 2D spectra were obtained
using 2,048 points for each tl value. For NOESY experiments, 512 tl
values were used, and for DQF-COSY experiments, 800 tl values were
acquired using 4,096 points in t2. Before Fourier transform, both time do-
main data were multiplied by ir/8- and ir/4-shifted sine bell functions for
t2 and tl domains, respectively.
2H NMR spectroscopy
2H NMR spectra were recorded on a Nicolet NT360B spectrometer, running
at 45 MHz for the 2H nucleus (Sankaram and Thompson, 1990b). A fixed-
frequency high-power variable-temperature probe, HP-50 from Cryomagnet
Systems, Inc. (Indianapolis, IN), with a 5-mm solenoid was used for the
2H NMR experiments. The sample temperature was controlled by a
Nicolet variable-temperature accessory. The quadrupole echo pulse se-
quence (Davis et al., 1976) was used with a 900 pulse with of 2.4 ,us.
The spectral width was 125 kHz. The interpulse delay was optimized
for each sample to obtain a digitized point at the top of a symmetric echo
and to minimize the imaginary part of the magnetization. The delay
values were generally between 30 and 60 ,us. A relaxation delay of 300
ms was used.
RESULTS
DQF-COSY and phase-sensitive NOESY of
acylated and nonacylated peptides
To facilitate the comparison between the two peptides in
nonacylated form, SerPep and ThrPep, and in
N-myristoylated form, MyrSerPep and MyrThrPep, the
NMR study was performed under the same pH (7.4), tem-
perature (25°C), and concentration (10 mM) conditions.
Sequence-specific assignment of the 1H NMR spectra was
carried out by well established methods (Wuthrich, 1986).
The different spin systems were identified using DQF-COSY
techniques. The connectivities between the adjacent spin
systems were established using NOESY spectra. Most of
in Table 1. The vicinal coupling constants between
the amide protons of residue i and the CaH protons of
i + 1 residue, 3JaW were greater than 8 Hz for all four
peptides.
The observed sequential and short-range NOEs are pre-
sented in Fig. 1. The NOEs between CaH and NH, NH
and NH, and Cf3H and NH protons of the i and i + 1 resi-
due, d.N, dNN, and doN respectively, are shown as lines
spanning the i and the i + 1 residue in Fig. 1. When the
diagonal peaks are positive and the cross-peaks are nega-
tive, the NOEs are shown as thin lines. When both the
diagonal peaks and the cross-peaks are positive, they are
shown as thick lines.
The same short-range, sequential NOEs were observed
for the N-myristoylated peptides, MyrSerPep and MyrThr-
Pep, as for the nonacylated peptides, SerPep and ThrPep,
but with the opposite sign. When the diagonal peaks were
positive, the cross-peaks were negative for the nonacylated
peptides, SerPep and ThrPep, and positive for the
N-myristoylated peptides, MyrSerPep and MyrThrPep. In
addition to dUN, dNN, and dON, two additional sequential
NOEs between protons of the myristoylated chain and pro-
tons of the amino acid residues were observed for both
MyrSerPep and MyrThrPep (see Fig. 1). One of them is an
NOE between the methylene protons adjacent to the car-
bonyl group in the myristoyl moiety and the NH protons of
the amide bond between myristic acid and N-Gly, d2N. The
other NOE is between the methylene protons of the myris-
toyl chain at positions 2 and 3, d23.
No long-range NOEs were observed either for the non-
acylated peptides, SerPep and ThrPep, or for the
N-myristoylated peptide, MyrSerPep. However, for
MyrThrPep, a set of long-range NOEs were observed be-
tween the combined resonance arising from the un-
resolved methylene groups at positions 4-13 in the
myristoyl group and the side-chain ,8 protons of Asp, Thr,
and Pro, d4-13. As mentioned above, the cross-peaks were
positive.
Peptide binding
SerPep, MyrSerPep, ThrPep, and MyrThrPep bind to
DMPC bilayers with different affinities. Binding curves
for SerPep and MyrSerPep are shown in Fig. 2 A, and
those for ThrPep and MyrThrPep are shown in Fig. 2 B.
The mole ratio of the bound peptide, P, to lipid, Lt, is
plotted as a function of the mole ratio of the initially
added peptide, Pt, to lipid, Lt. The data were fit to
simple mass action binding to determine the lipid:pep-
tide stoichiometry at saturation, n, and the equilibrium
binding constant, K. At saturation, 1 mol of SerPep was
bound to 29.3 ± 0.6 mol of DMPC, 1 mol of MyrSer-
Pep was bound to 34.7 ± 0.2 mol DMPC, 1 mol of
ThrPep was bound to 20.0 ± 0.4 mol of DMPC, and 1
mol of MyrThrPep was bound to 7.3 ± 0.2 mol of
DMPC. The binding constants were 3058 ± 327 M1
the protons were assigned, and the results are reported
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for SerPep, 30200 ± 5408 M-' for MyrSerPep, 4715 ±
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FIGURE 1 Amino acid sequence of (A) SerPep and MyrSerPep, and (B) ThrPep and MyrThrPep with summary of NOESY cross-peaks. NOESY
cross-peaks are indicated by lines connecting the amino acid/amino acid or fatty acid/amino acid residues. Both short-range sequential NOEs (dN, dNN, dIN,
d2N, d23) and the long-range NOE, d4_,3,, are shown. The thin lines correspond to negative cross-peak NOE intensities, and the thick lines correspond to positive
cross-peak NOE intensities, both with positive diagonal peaks. See Table 1 for 1H chemical shifts. The peptide concentration was 10 mM in 90% H20/10%
D20 at pH 7.4. The NMR spectra were recorded at 25°C.
50 M1 for ThrPep, and 4012 ± 289 M-1 for MyrThr-
Pep. The values for the stoichiometry and binding con-
stant given above include the mean and the SD from
the curve-fitting procedure.
ESR spectra of acylated and nonacylated
peptides
The interaction of SerPep and ThrPep in N-myristoylated
form and nonacylated form with phospholipid bilayers was
investigated by ESR spectroscopy. ESR spectra at 30°C
and at a 1 mol% concentration of a phospholipid spin la-
bel, 16-PCSL, and of a fatty acid spin label, 16-SASL, in
DMPC bilayers in the presence and absence of the
N-myristoylated peptides, MyrSerPep and MyrThrPep, are
shown in Fig. 3, a, b, c, and e, respectively. The ESR
spectra are characteristic of a nitroxide spin label located
in the hydrophobic region of membranes in the liquid crys-
talline phase.
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FIGURE 2 Binding of (A) SerPep,
MyrSerPep, and (B) ThrPep and MyrThrPep
to DMPC bilayers. The bound peptide:lipid
mole ratio, PIL,, is plotted against the initial
peptide:lipid mole ratio, P/L,, for SerPep (0),
MyrSerPep (0), ThrPep (L), and MyrThrPep
(U). The lines represent simple mass action
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ESR spectra at 30°C and at a 1 mol% concentration of the
spin-labeled acylated peptides, 16-SteSL-SerPep and 16-
SteSL-ThrPep, in DMPC bilayers are also shown in Fig. 3,
d and f, respectively. The spectrum of 16-SteSL-SerPep is
similar to that obtained with 16-PCSL or with 16-SASL in
DMPC bilayers with and without MyrSerPep and MyrThr-
Pep. In contrast, the spectrum of 16-SteSL-ThrPep is exten-
sively spin-spin-broadened.
2H NMR spectroscopy
Lipid-peptide interactions between DMPC and MyrSerPep
or MyrThrPep were also investigated using 2H NMR. The 2H
NMR spectrum at 30°C obtained from perdeuterated DMPC,
DMPC-d54, bilayers is shown in Fig. 4 a. This spectrum is
an axially symmetric powder pattern characteristic of lipid
bilayers in the liquid crystalline phase. The 2H NMR spectra
at 30°C of DMPC-d54 in the presence of the N-myristoylated
peptides, MyrSerPep and MyrThrPep, are similar in shape
and in magnitude ofquadrupole splittings to those ofpeptide-
free DMPC-d54 bilayers (spectra not shown).
The 2H NMR spectra at 300C of DMPC bilayers contain-
ing the acylated peptides with perdeuterated acyl chains,
Myr-d27-SerPep and Myr-d27-Thr-Pep, at a DMPC:peptide
mole ratio of - 30: 1 are shown in Fig. 4, b and c, respectively.
The spectrum of the DMPC-Myr-d27-SerPep system re-
sembles that of DMPC-d54, indicating that the orientational
order of the covalently linked fatty acid in Myr-d27-SerPep
is similar to that of the myristoyl chains of the host bilayer
lipid, DMPC. The quadrupole splittings of the perdeuterated
myristoyl chain in Myr-d27-SerPep (Fig. 4 b) are somewhat
smaller (up to 20%) than those of the perdeuterated myristoyl
chains of DMPC-d54. This might be because the peptide-
linked fatty acyl chains are more disordered than those of the
host lipids. In contrast, the spectrum of the DMPC-Myr-d27-
ThrPep has a complex line shape that may correspond either
to the no-motion limit such as would be observed for lipids





FIGURE 3 ESR spectra of acylated peptides reconstituted into DMPC
bilayers. In each case the spin label concentration was 1 mol%. All of the
spectra were recorded at 30°C with a modulation amplitude of 1 G and scan
range of 100 G. (a) 16-PCSL in DMPC bilayers (b) 16-SASL in DMPC
bilayers, (c) 16-PCSL in DMPC bilayers containing MyrSerPep, (d) the
spin-labeled peptide, 16SteSL-SerPep, in DMPC bilayers, (e) 16-PCSL in
DMPC bilayers containing MyrThrPep, and (f) the spin-labeled peptide,
16SteSL-ThrPep, in DMPC bilayers. The bound lipid:peptide mole ratio in
all cases was 100:1.
DISCUSSION
Lipid binding of myristoylated and nonacylated
peptides
The analysis of the thermodynamics of peptide binding to
membranes must take into account the fact that binding of
charged peptides to membranes leads to a negative cooper-
ativity of binding (Cevc and Marsh, 1987; Kim et al., 1991;
Mosior and McLaughlin, 1991; Mosior and McLaughlin,
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FIGURE 4 2H NMR spectra of acylated peptides reconstituted into
DMPC bilayers. All of the spectra were recorded at 30°C. The bound lipid:
peptide mole ratio was -30:1. (a) DMPC-d54 bilayers; (b) DMPC bilayers
containing the SerPep with a covalently linked perdeuterated myristoyl
chain; Myr-d27-SerPep; and (c) DMPC bilayers containing the ThrPep with
a covalently linked perdeuterated myristoyl chain, Myr-d27-ThrPep.
1992; Sankaram and Marsh, 1993). As more peptide is
bound, the binding becomes weaker as given by
K = K exp(<-Ze;) (1)
where K is the effective binding constant, Ko is the intrinsic
binding constant, Ze is the net effective charge on the peptide,
(F is the surface potential, k is the Boltzmann constant, and
T is the absolute temperature. This is because, as more nega-
tively charged peptide is bound to the zwitterionic DMPC
bilayers, further binding of the peptide is attenuated by an
electrostatic repulsion between the negatively charged
peptide-bound membranes and the negatively charged pep-
tide. SerPep, ThrPep, MyrSerPep, and MyrThrPep have a
net charge of -2, 0, -3, and -1, respectively. According to
Eq. 1, binding of the peptides with a net negative charge to
the zwitterionic DMPC bilayers results in a value for K
smaller than that for KO. If the lipid:peptide interactions are
entirely electrostatic in nature for the four peptides, then the
ratios of ln K for the peptides must correspond to the ratios
of the net charges of them (Sankaram and Marsh, 1993).
This is not the case because the ln K values are in the ratio
(SerPep:ThrPep:MyrSerPep:MyrThrPep) 0.78:0.82:0.80:1.00,
whereas the values ofZ are in the ratio 2:0:3:1. The fact that
the lnK values are nearly the same for SerPep (Z = -2) and
ThrPep (Z = 0) renders invalid the assumption that the in-
trinsic binding constant, KO, is the same for the two peptides.
If it is assumed that Eq. 1 holds for all the four peptides,
then the observation that the ratios of the lnK values do not
follow the ratios ofZ for the four peptides suggests either that
the intrinsic binding constant, KO, is not the same for the four
peptides or that the interaction among SerPep, ThrPep,
MyrSerPep, and MyrThrPep and lipid bilayers is not entirely
electrostatic in nature. It is also possible that the acylated and
nonacylated peptides all have different KO values and that the
interaction with the membrane contains nonelectrostatic
components. The nonelectrostatic component might arise for
the acylated peptides from interaction of the covalently
linked myristoyl moiety with DMPC bilayers and/or with the
peptides. An examination of both the lipid:peptide stoichi-
ometry at saturation binding, n, measured for the peptides
and the calculated binding constants, K, strongly argues in
favor of this hypothesis. SerPep has a value for n of 20 and
a binding constant of 3058 M-1. The value of n for the
N-myristoylated peptide, MyrSerPep, is 34, whereas the
binding constant is increased to 30,200 M-1. The increase in
K upon myristoylation is most likely due to the interaction
of the covalently linked myristoyl chain with the myristoyl
chains of DMPC, whereas the increase in n is due to an
increase in the net negative charge. In contrast, the binding
constant, K, of 4715 M1 for ThrPep is decreased to 4012
M1 upon myristoylation, whereas n is decreased from a
value of 20 for ThrPep to 7 for MyrThrPep. The small de-
crease in K is probably due to the increased net negative
charge upon myristoylation. Because the binding constant is
not increased upon myristoylation of the ThrPep, it is un-
likely that the covalently linked myristoyl chains interact
with the DMPC host membrane. The concomitant decrease
in n indicates that the MyrThrPep may be bound to DMPC
bilayers in an aggregated form.
Solution conformations of N-myristoylated and
nonacylated peptides
The results of the NOESY experiments shown in Fig. 1 re-
veal three different effects of N-myristoylation on peptide
structure and conformation in solution. First, values for 3'JN
larger than 8 Hz indicate that the peptides, whether
N-myristoylated or not, do not have a stable folded confor-
mation. This result is expected because the peptides are too
short to adopt an a-helical or other well defined secondary
structure. Second, the sign of the NOE is changed upon
N-myristoylation of both SerPep and ThrPep. For SerPep and
ThrPep, the NOE cross-peaks are negative with positive di-
agonal peaks. This result reflects the small size of the pep-
tides. In this case, the relaxation is in the extreme motional
narrowing regime, and the condition that Tc&r << 1 (w0 is
spectrometer frequency that at 500 MHz is 3 10-" s-1; T" is
the correlation time) is satisfied. However, for MyrSerPep
and MyrThrPep the cross-peaks are positive with positive
diagonal peaks. Thus, N-myristoylation results in an aggre-
gation of both peptides. The third effect of N-myristoylation
is on the relative orientation of the myristoyl chain with re-
spect to the amino acid residues in MyrSerPep and MyrThr-
Pep. For MyrSerPep, no long-range NOEs were observed. As
seen in Fig. 1 for MyrThrPep, NOEs were observed between
the methylene protons of the fatty acid and the side-chain
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protons of Thr and Pro. The average distance between the
sets of protons between which the long-range NOEs were
observed is known to be less than about 5 A (Wuthrich,
1986).
The 2D NMR results suggest that the nonacylated pep-
tides, SerPep and ThrPep, are unstructured monomers in so-
lution, whereas the acylated peptides MyrSerPep and
MyrThrPep are aggregated in solution. Although both
MyrSerPep and MyrThrPep are aggregated in solution, the
structures for the aggregates of the two peptides must be
different. No NOE evidence for the presence of local struc-
ture was found for MyrSerPep. A possible structure for the
aggregate, shown in Fig. 5 a, is similar to that of a micelle.
On the other hand, the individual MyrThrPep molecules in
the soluble aggregate have a local structure in which the acyl
chain is close to the amino acid residues. As shown in Fig.
5 b for MyrThrPep, a possible result of placing the myristoyl
chain within a 5-A distance of the uncharged residues Thr
and Pro is that the side chains of the charged residues Arg
and Asp are located away from the hydrophobic myristoyl
chain. This arrangement leads to an amphipathic structure for
the aggregate that is stabilized by a hydrophobic core formed
by the myristoyl chains (see Fig. 5 b).
Lipid-peptide interactions with acylated peptides
The ESR and 2HNMR results presented in Figs. 3 and 4 show
that N-myristoylation leads to different modes of lipid-
peptide interactions for the two peptides. The ESR spectra of
nitroxide-derivatives of phospholipids and fatty acids in
DMPC membranes in the presence and absence of 16-SteSL-
SerPep are characteristic of freely diffusing probes in mem-
branes. The 2H NMR results obtained with Myr-d27-SerPep
(Fig. 4 b) confirm these results. The spectrum of this peptide
is axially symmetric, indicating that a fluid environment
similar to the host lipid bilayer. The quadrupole splittings for
a
FIGURE 5 A schematic illustration of the possible
structures for SerPep, ThrPep, MyrSerPep, and
MyrThrPep in solution and when bound to mem-
branes. (a) MyrSerPep in solution; (b) MyrThrPep in
solution; (c) MyrSerPep bound to membranes by a
direct insertion of the myristoyl chain into the lipid
bilayer; and (d) MyrThrPep bound to membranes by
lipid-protein interaction. The number of peptides per
aggregate and the shape of the aggregate used to draw
this figure are only for illustrative purposes.
C
this peptide are about 20% smaller than those for the host
lipids at the same temperature, presumably because of a
deeper vertical bilayer location of the covalently linked fatty
acid than that of the fatty acid chains of the host lipid. These
observations suggest that N-myristoylation most likely re-
sults in membrane binding of MyrSerPep by an "anchoring"
mechanism, in which the covalently linked fatty acid is di-
rectly inserted into the lipid bilayer (see Fig. 5 c).
For 16-SteSL-ThrPep, the ESR spectral line-broadening
suggests the formation of peptide aggregates that bind to
membranes. The 2H NMR data on Myr-d27-ThrPep (Fig. 4 c)
show that the covalently linked myristoyl chain in this pep-
tide does not undergo the gel-fluid phase transition at the
same temperature as the myristoyl chains of the host lipid,
DMPC, membranes. The covalently linked perdeuterated
myristoyl chain of Myr-d27-ThrPep, when bound to DMPC
membranes, exhibits a gel-fluid transition at 35°C, whereas
in DMPC-d54-MyrThrPep complexes, the perdeuterated
myristoyl chains of DMPC-d54 melt at 23°C (results not
shown).
These observations indicate that membrane binding in this
case occurs between an aggregate of the peptide and is me-
diated by a direct contact between the amino acid residues
and phospholipid headgroups. In this model, shown in Fig.
5 d, the covalently linked myristoyl chains are not in direct
contact with the host lipid myristoyl chains. Thus, membrane
binding is not accompanied by an anchoring of the fatty acyl
chains. The size of the complexes, i.e., the number of in-
teracting monomeric units, and the geometrical arrangement
of the units shown in Fig. 5 is not obtainable from the present
work. The number of peptides per aggregate and the shape
of the aggregate used to draw this figure are only for illus-
trative purposes. It should be emphasized that these are
simple models that are consistent with the spectroscopic data.
The aggregation state of amphipathic molecules, such as
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tide concentration. Because the peptide concentration was 10
mM for 2D NMR experiments, MyrSerPep and MyrThrPep
must be aggregated at concentrations above 10 mM. How-
ever, because the binding curves obtained for MyrSerPep
and MyrThrPep (at a phospholipid concentration of 13 mM
and in the peptide concentration range 0.1-4 mM) are not
biphasic, it is likely that these peptides are aggregated at
concentrations above 0.13 mM.
Based on these results, the origin of the effect of
N-myristoylation on peptide aggregation in solution and on
membrane binding cannot be attributed to the presence of Ser
at position 5. Thus, this highly conserved residue is probably
required for recognition by N-myristoyl transferase and not
for regulating the biological function of N-myristoylated
proteins.
It is demonstrated here that binding of N-myristoylated
peptides to membranes is not always by a membrane-
anchoring mechanism. The present data provide evidence for
membrane-anchoring (direct insertion of the covalently
linked fatty acid into the lipid bilayer) and for peptide-
peptide association (no direct contact between the covalently
linked fatty acid and the acyl chains of the host lipids). Spe-
cifically, these results suggest that in biological systems
N-myristoylation can lead to protein-protein association if
the N-terminal sequence adopts a conformation in which the
covalently linked myristic acid lies close to the neutral or
hydrophobic face of the structure with the charged residues
residing on the apposing face. If N-myristoylation of a cy-
tosolic protein does not result in protein-protein association,
the protein is most likely to be anchored to a membrane. If
protein-protein association does occur, membrane-binding is
expected to be determined by the energetics of solvation
versus lipid-protein interactions of the protein aggregate. It
should be mentioned that the choice of short peptides for this
study has proven useful to differentiate between the two
modes of interaction, while ignoring contributions from pro-
tein conformational changes. The logical step now is to carry
out this study systematically with proteins or larger peptides
with the aim of determining the effect of N-myristoylation
on secondary structure.
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